Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
29 Cards in this Set
- Front
- Back
Erythromycin
(class, MoA) |
macrolide
Binds domain V of 50S ribosome |
|
Erythromycin
(resistance) |
efflux pump
mutation at ribosomal binding site methylation of ribosomal binding site (INDUCES methyltransferases) |
|
Clarithromycin
(class, MoA, adverse rxn) |
Macrolide
binds domain V of 50S ribosome CNS disturbances (mania) |
|
Azithromycin
(class, MoA) |
macrolide
binds domain V of 50S ribosome |
|
Azithromycin
(absorbtion & spectrum) |
pneumococci, strep, staph, mycoplasma, legionella, chlamydia, MAC, H.flu
very high tissue conc (acts as reservoir) |
|
Telithromycin
(class & MoA & treatment of) |
ketolide
binds domains II and V of 50S ribosome treatment of comm acquired pneumonia |
|
Clindamycin
(class & MoA & adverse effect) |
Lincosamide
binds domain V of 50S ribosome pseudomembranous colitis |
|
Clindamycin
(absorption & spectrum) |
affinity for osseous tissue (bone infections)
spectrum includes MRSA & B.frag |
|
Quinupristin/Dalfopristin
(class & MoA) |
streptogramin
binds a site on 50S ribosome |
|
Quinupristin/Dalfopristin
(spectrum & adverse effect) |
Gm+ ONLY
effective against many drug resistant bacteria (VREF, MRSA, MDR S.pneumo) arthralgias & myalgias |
|
Linezolid
(class & MoA) |
Oxazolidinone
Binds 50S ribosome |
|
Linezolid
(spectrum & adverse effects) |
Gm+ ONLY
VRE, MRSA & MDR resistant S. pneumo myelosuppression, anemia, serotonin syndrome |
|
Chloramphenicol
(MoA & adverse effects) |
binds 50S ribosome
aplastic anemia, anemia, gray baby syndrome |
|
Tetracycline
(class & MoA) |
tetracyclines
inhibits 30S ribosome |
|
Tetracycline
(resistance & spectrum) |
efflux pump
rickettsiae, chlamydiae, mycoplasmas, H.pylori, plasmodia, amoebas |
|
Tetracycline
(adverse reactions) |
hypersensitivity, GI, phototoxic reaction, hepatic dysfunction, discoloration of teeth, depressed bone growth (binds Ca2+)
|
|
Minocycline
(class & MoA) |
tetracyclines
inhibits 30S ribosome |
|
Minocycline
(adverse effects) |
vertigo & dizziness
|
|
Doxycycline
(class & MoA & primary use) |
tetracyclines
inhibits 30S ribosome chlamydia |
|
Tigecycline
(MoA) |
HIGH affinity for 30S ribosome
unaffected by efflux pump |
|
Tigecycline
(spectrum) |
broad spectrum
MRSA, VRE, PRSP, carbapenem resistant actinobacter |
|
Gentamicin
(class & MoA) |
aminoglycosides
interferes w attachment of mRNA to 30S ribosome (initiation) |
|
Tobramycin
(class & MoA) |
aminoglycosides
interferes w attachment of mRNA to 30S ribosome (initiation) |
|
Amikacin
(class & MoA) |
aminoglycosides
interferes w attachment of mRNA to 30S ribosome (initiation) |
|
Aminoglycosides spectrum
|
Gm(-) AEROBES
|
|
Aminoglycosides dosing
|
based on lean body mass
once daily dosing minimizes SEs (lower trough levels) |
|
Aminoglycosides resistance
|
due to metabolism by bacteria to inactive compounds
|
|
Aminoglycosides adverse reactions
|
ototoxicity, nephrotoxicity, neuromuscular blockade
|
|
what does uptake of aminoglycosides depend on?
how does this relate to spectrum? |
O2
Gm- aerobes |